Trademark Search in Canada

IMMUDEX

View On IC.GC.CA

REGISTERED

on 16 Jan 2023

Last Applicant/ Owned by

IMMUDEX APS

Fruebjergvej 32100 København Ø

Serial Number

1934637 filed on 6^th Dec 2018

Registration Number

TMA1160781 registered on 16^th Jan 2023

Registration expiry Date

16^th Jan 2033

Correspondent Address

FURMAN IP LAW & STRATEGY PC

260-10 Research DriveOffice D/EREGINA

SASKATCHEWAN

S4S7J7

IMMUDEX

Trademark usage description

chemicals used in medical diagnostics and treatment in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, tb vaccines, hiv-v Read More

Classification Information

Class [001]
Chemicals used in medical diagnostics and treatment in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; diagnostic preparations for medical-scientific research use; diagnostic reagents for medical-scientific research use; diagnostic reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; research reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; diagnostic test materials for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumours and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T cell monitoring; diagnostic kits for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TBvaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; assays for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TBvaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; biochemical reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TBvaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TBvaccines, HIV-vaccines, CMVvaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; chemical reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TBvaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring

Classification kind code

Class [005]
Preparations for pharmaceutical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes for use in the diagnosis and treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; reagents for medical and veterinary purposes for use in the diagnosis and treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccines, immunotherapeutics and cellular therapies, cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy and other therapy, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, infectious diseases, and for use in connection with medical procedures and diagnosis, namely transplantation, immune monitoring, and vaccines and T-cell monitoring

Classification kind code

Class [042]
Scientific and technological services and research and design services in the field of medicine and vaccine development; diagnostic services related to research in the field of medicine and vaccine development; industrial analysis and research services in the field of medicine and vaccine development; basic research and clinical research, hereunder for medicine and vaccine development; research and development in the field of diagnostic preparations in the field of medicine and vaccine development

Classification kind code

Mark Details

Serial Number

1934637

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 191 on 19^th Oct 2022	Registration Fee Notice Sent
Submitted for opposition 190 on 19^th Oct 2022	Registration Pending
Submitted for opposition 42 on 27^th Jul 2022	Advertised
Submitted for opposition 27 on 7^th Jun 2022	Approval Notice Sent
Submitted for opposition 26 on 7^th Jun 2022	Approved
Submitted for opposition 22 on 1^st Nov 2021	Search Recorded
Submitted for opposition 20 on 1^st Nov 2021	Examiner's First Report
Submitted for opposition 31 on 14^th Dec 2018	Formalized
Submitted for opposition 1 on 7^th Dec 2018	Created
Submitted for opposition 30 on 6^th Dec 2018	Filed